Recent offering made by $HMTXF only for existing shareholders

The offering constituting the private non-brokered placement of 15 Million units is only available to existing shareholders of the company, who as of the closing of business on May 16, 2022 hold common shares of Hemostemix
Fundamental AnalysisinvestingpennystockssmallcapstocksStocksstockstobuystockstradingtradingview

כתב ויתור